MT has numerous deliverables - kicking off Ph2/3 trial but one of them.
I doubt anybody care's that you don't care that the company has issued a new timeline for the trial. Whilst that's arguable (you've mentioned it on the odd 50 or 60 occasions as you're focussed on a single occurrence where H1 2024 was mentioned), the situation is that the Company has made clear it starts in H2 CY 2024.
Ann: OLE Study update reveals impressive Survival Data, page-184
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $5.838K | 33.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 103011 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 91045 | 4 |
View Market Depth
| Last trade - 11.09am 15/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |